Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
2.2K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

5.9K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.9K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

3.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.4K
Bacterial Toxins01:12

Bacterial Toxins

148
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
148
Diphtheria01:28

Diphtheria

175
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic performance of discriminant formulas and machine learning models for detecting β-thalassemia trait in Bangladesh.

PloS one·2026
Same author

Thermopower Probe of Fractional Quantum Hall States in Monolayer Graphene.

Physical review letters·2026
Same author

Use of telehealth did not mitigate persistent disparities in prenatal care access among American Indian women in North Dakota.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2025
Same author

Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.

PloS one·2025
Same author

Electron transport in bilayer graphene nano constrictions patterned using AFM nanolithography.

Physical review. B·2025
Same author

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Cureus·2025

Related Experiment Video

Updated: May 1, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.0K

Botulinum toxin: The Midas touch.

P S Shilpa1, Rachna Kaul1, Nishat Sultana1

  • 1Department of Oral Medicine and Radiology, Vydehi Institute of Dental Sciences, No. 82, EPIP Area, White Field, Bangalore, India.

Journal of Natural Science, Biology, and Medicine
|March 29, 2014
PubMed
Summary

Botulinum toxin (BT), a natural molecule from Clostridium botulinum, is increasingly used for cosmetic and therapeutic applications. This review covers BT

Keywords:
Botulinum toxinhead and neck diseasetemperomandibular diseases

More Related Videos

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

15.6K
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.5K

Related Experiment Videos

Last Updated: May 1, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.0K
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

15.6K
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.5K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Applications

Background:

  • Botulinum toxin (BT) is a neurotoxin produced by Clostridium botulinum bacteria.
  • Its use for cosmetic enhancement has surged in popularity over the last 20 years.
  • Emerging research highlights diverse therapeutic applications for BT.

Purpose of the Study:

  • To review the fundamental nature and mechanism of action of Botulinum Toxin.
  • To explore the current and potential applications of BT in treating head and neck diseases.
  • To assess BT's role as a minimally invasive treatment for orofacial disorders.

Main Methods:

  • Literature review of scientific articles on Botulinum Toxin.
  • Analysis of studies detailing BT's biochemical properties and physiological effects.
  • Compilation of data on clinical applications in head and neck conditions.

Main Results:

  • Botulinum toxin functions by inhibiting neurotransmitter release at neuromuscular junctions.
  • It has demonstrated efficacy in treating various orofacial and head/neck conditions.
  • BT offers a minimally invasive option to improve patient quality of life.

Conclusions:

  • Botulinum toxin is a versatile molecule with established cosmetic and growing therapeutic uses.
  • Its mechanism of action supports its application in a range of neurological and muscular disorders.
  • Further research into BT applications can significantly benefit patients with head and neck diseases.